OTCs: A New Growth Opportunity?

11 March 1996

The political and economic trends in the health care marketplace indicate a continuing move towards greater individual responsibility for health care and encouragement of self-treatment, according to Gilbert Mertens, international marketing manager at Merck Pharmacy Healthcare, speaking at a self-medication seminar in Lisbon, Portugal, this month.

He believes that as health care reforms of recent years start taking effect, managed care will emerge as a possibility in Europe, for example in the UK, the Netherlands and in Switzerland. "Many of us in the pharmaceutical industry feel we are being punished by price reductions and slashed margins, and are turning to the non-prescription sector to extend the product lifecycle and, above all, to exploit new growth opportunities," he said.

The 1980s brought the first serious signs of escalating costs, leading towards today's cost-cutting measures and confirming the high cost to the state of making available the treatment for minor ailments through the prescription route.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight